Invention Grant
- Patent Title: Method for development of monoclonal antibodies
-
Application No.: US15764990Application Date: 2016-09-30
-
Publication No.: US10995134B2Publication Date: 2021-05-04
- Inventor: Gaily Kivi , Kaupo Teesalu , Jüri Parik , Mart Ustav , Andres Männik
- Applicant: Icosagen Cell Factory OÜ
- Applicant Address: EE Tartumaa
- Assignee: Icosagen Cell Factory OÜ
- Current Assignee: Icosagen Cell Factory OÜ
- Current Assignee Address: EE Tartumaa
- Agency: Berggren LLP
- International Application: PCT/EP2016/073524 WO 20160930
- International Announcement: WO2017/055617 WO 20170406
- Main IPC: C07K16/08
- IPC: C07K16/08 ; C07K16/00 ; C07K16/10 ; C07K16/40 ; C07K16/22
Abstract:
This invention provides a method and a kit for rapid and robust development monoclonal antibodies. The method does not require hybrid technologies nor does it require single cell manipulations. The method allows elimination of cross-target antibodies.
Public/Granted literature
- US20180273611A1 A method for development of monoclonal antibodies Public/Granted day:2018-09-27
Information query
